Canon Medical Systems recently introduced AiCE (Advanced intelligent Clear IQ Engine), a deep convolutional neural network (DCNN) image reconstruction technology for computed tomography (CT). AiCE uses deep learning technology to differentiate signal from noise so that it removes noise while it preserves true signal.
This is a virtual heart with the same electrophysiology characteristics as the real patient being developed to help ...
Ra Medical Systems Inc. announced a 98 percent success rate in the results from a 52-patient study using the company’s DABRA System for the treatment of above- and below-the-knee peripheral artery disease (PAD). The data was presented by Ashok Kondur, M.D., FACC, FSCAI at the 2019 Leipzig Interventional Course (LINC) in Leipzig, Germany.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Philips announced the launch of IntelliSpace Portal 11, the latest release of the company’s comprehensive, advanced visualization and quantification software. Launching at the 2019 European Congress of Radiology (ECR), Feb. 27-March 3 in Vienna, Austria, the new version further extends the clinical innovation of the portal, with enhancements to improve workflow efficiencies, bridging secure data sharing between systems within the hospital network to address the security and privacy needs of customers globally.
Steve Holloway, principal analyst and company director for the healthcare market research firm Signify Research ...
Diagnostic and Interventional Cardiology has been recognized as a finalist in the Jesse H. Neal Awards for the third year in a row. DAIC editor Dave Fornell was named a finalist in the Best Range of Work by a Single Author category for his reporting from the Transcatheter Cardiovascular Therapeutics (TCT) 2018 conference, that included blog posts and video coverage.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
GE Healthcare announced Feb. 25 the sale of its biopharmaceutical business to Danaher, and GE Chairman and CEO Larry Culp Jr. said the deal signified that a planned 2019 initial public offering (IPO) for GE Healthcare is now unlikely. GE is reportedly weighing its options following the deal, which casts off the biopharmaceutical business for $21.4 billion.
Here is what I thought were the top five most important take-away presentations from the 2019 Society of Thoracic ...
Philips will unveil a new mixed reality concept developed together with Microsoft that the company says is designed for the operating room of the future. Based on Philips’ Azurion image-guided therapy platform and Microsoft’s HoloLens 2 holographic computing platform, the companies will showcase novel augmented reality applications for image-guided minimally invasive therapies. The technology will debut at Mobile World Congress (MWC) Barcelona, Feb. 25-28 in Barcelona, Spain.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22 ...
February 22, 2019 — The U.S. Food and Drug Administration (FDA) has approved the Biotronik Orsiro drug-eluting stent ...
At the recent Healthcare Information and Management Systems Society (HIMSS) annual conference, AT&T’s healthcare team demonstrated the key role connectivity and the internet of medical things (IoMT) plays throughout the continuum of care. This concept was highlighted by a demonstration of the Bodyport remote monitoring solution.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The device was approved to facilitate, guide and support a guidewire while accessing the coronary system, the exchange of guidewires, and injection of radiopaque contrast media or saline solutions.
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the increased risk of ...
Medtronic is recalling its dual chamber implantable pulse generators (IPGs) due to the possibility of a software error that can result in a lack of pacing. Patients and physicians cannot predict whether and when this software error might occur. A lack of pacing could result in patients experiencing slow heart beating, low blood pressure, and symptoms such as light headedness, fainting and even death.